304 related articles for article (PubMed ID: 19967367)
1. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers.
Palussiere J; Lagarde P; Aupérin A; Deschamps F; Chomy F; de Baere T
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):160-6. PubMed ID: 25394595
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
[TBL] [Abstract][Full Text] [Related]
4. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
5. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
6. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
[No Abstract] [Full Text] [Related]
9. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
[TBL] [Abstract][Full Text] [Related]
10. Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy.
Schoellnast H; Deodhar A; Hsu M; Moskowitz C; Nehmeh SA; Thornton RH; Sofocleous CT; Alago W; Downey RJ; Azzoli CG; Rosenzweig KE; Solomon SB
Acta Radiol; 2012 Oct; 53(8):893-9. PubMed ID: 22961644
[TBL] [Abstract][Full Text] [Related]
11. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
13. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study.
Okuma T; Matsuoka T; Yamamoto A; Hamamoto S; Nakamura K; Inoue Y
Br J Radiol; 2009 Dec; 82(984):989-94. PubMed ID: 19470575
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
15. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
16. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.
Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Soh J; Toyooka S; Kiura K; Kanazawa S
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):409-15. PubMed ID: 24938905
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
19. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
20. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
de Baère T; Palussière J; Aupérin A; Hakime A; Abdel-Rehim M; Kind M; Dromain C; Ravaud A; Tebboune N; Boige V; Malka D; Lafont C; Ducreux M
Radiology; 2006 Aug; 240(2):587-96. PubMed ID: 16864679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
